These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3282870)
1. Is tiaprofenic acid different from other NSAIDs with regard to effects on renal function in the elderly? Ishioka T Drugs; 1988; 35 Suppl 1():95-100. PubMed ID: 3282870 [TBL] [Abstract][Full Text] [Related]
2. The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial. Scott DL; Berry H; Capell H; Coppock J; Daymond T; Doyle DV; Fernandes L; Hazleman B; Hunter J; Huskisson EC; Jawad A; Jubb R; Kennedy T; McGill P; Nichol F; Palit J; Webley M; Woolf A; Wotjulewski J Rheumatology (Oxford); 2000 Oct; 39(10):1095-101. PubMed ID: 11035129 [TBL] [Abstract][Full Text] [Related]
3. The effect of tiaprofenic acid on uric acid excretion in man. Sinigaglia L; Zeni S; Solazzi F; Di Minno G; Longatti S Drugs; 1988; 35 Suppl 1():68-71. PubMed ID: 3359948 [TBL] [Abstract][Full Text] [Related]
4. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Sorkin EM; Brogden RN Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353 [TBL] [Abstract][Full Text] [Related]
5. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542 [TBL] [Abstract][Full Text] [Related]
6. Multicentre double-blind comparison of sustained action formulations of tiaprofenic acid and indomethacin in osteoarthritis. Calin A; Cawley MI; Pal B; Rosenberg JN; Silas AM; Williams PI Drugs; 1988; 35 Suppl 1():57-63. PubMed ID: 3282867 [TBL] [Abstract][Full Text] [Related]
7. Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect. Katona G; Burgos-Vargas R Drugs; 1988; 35 Suppl 1():72-80. PubMed ID: 3359949 [TBL] [Abstract][Full Text] [Related]
8. Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases. Plosker GL; Wagstaff AJ Drugs; 1995 Dec; 50(6):1050-75. PubMed ID: 8612471 [TBL] [Abstract][Full Text] [Related]
9. Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media. Duan SB; Wu HW; Luo JA; Liu FY Nephron; 1999; 83(2):122-5. PubMed ID: 10516490 [TBL] [Abstract][Full Text] [Related]
10. Treatment of osteoarthritis: a 3-month comparison between tiaprofenic acid and indomethacin. Meurice J Curr Med Res Opin; 1983; 8(5):295-301. PubMed ID: 6340970 [TBL] [Abstract][Full Text] [Related]
11. Comparison of gastrointestinal blood loss in healthy male volunteers during repeated administration of standard and sustained action tiaprofenic acid and sustained release indomethacin. Warrington SJ; Dana-Haeri J; Horton MA; Thornton EJ Drugs; 1988; 35 Suppl 1():90-4. PubMed ID: 3258815 [TBL] [Abstract][Full Text] [Related]
12. Increased serum lithium concentration secondary to treatment with tiaprofenic acid and fosinopril. Alderman CP; Lindsay KS Ann Pharmacother; 1996 Dec; 30(12):1411-3. PubMed ID: 8968454 [TBL] [Abstract][Full Text] [Related]
13. Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis. Niccoli L; Bellino S; Cantini F Clin Exp Rheumatol; 2002; 20(2):201-7. PubMed ID: 12051399 [TBL] [Abstract][Full Text] [Related]
14. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Daymond TJ; Rowell FJ Drugs; 1988; 35 Suppl 1():4-8. PubMed ID: 3162870 [TBL] [Abstract][Full Text] [Related]
15. Comparative double-blind study of tiaprofenic acid versus piroxicam in the treatment of osteoarthritis of the knee. Maccagno A; Sebastian O; Di Giorgio E Drugs; 1988; 35 Suppl 1():64-7. PubMed ID: 3282868 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B. Li ZD; Luo J; Jia LH; Wang XY; Xun ZK; Liu M Hum Exp Toxicol; 2019 Feb; 38(2):193-200. PubMed ID: 30016892 [TBL] [Abstract][Full Text] [Related]
17. The effect of etodolac administration on renal function in patients with arthritis. Shand DG; Epstein C; Kinberg-Calhoun J; Mullane JF; Sanda M J Clin Pharmacol; 1986 Apr; 26(4):269-74. PubMed ID: 2939116 [TBL] [Abstract][Full Text] [Related]
18. Fixed drug eruption due to tiaprofenic acid. Tursen U; Bicer A; Kaya TI; Ikizoglu G J Dermatolog Treat; 2002 Dec; 13(4):205-6. PubMed ID: 19753743 [TBL] [Abstract][Full Text] [Related]
19. Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Amici G; Virga G; Da Rin G; Grandesso S; Vianello A; Gatti P; Bocci C Nephron; 1993; 65(3):469-71. PubMed ID: 8290003 [TBL] [Abstract][Full Text] [Related]
20. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. Field TS; Gurwitz JH; Glynn RJ; Salive ME; Gaziano JM; Taylor JO; Hennekens CH J Am Geriatr Soc; 1999 May; 47(5):507-11. PubMed ID: 10323640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]